Henderson Morley plc focuses on the development of drugs and vaccines for the pharmaceutical industry. The Company has been developed specifically to carry out preliminary sourcing and screening of candidates to combat diseases caused by the herpes family of viruses and DNA (deoxyribonucleic acid) viruses, including HSV1, HSV2 Papilloma virus infections (the cause of warts and cancer of the cervix in women), and Adenovirus, which is the cause of infections of the eye (conjunctivitis), as well as other viruses that cause infections in animals, such as feline herpes virus (cat flu). The Company's products are outlicensed to a commercial partner, which will assume the responsibility of progressing candidates through the clinical trial process. Henderson Morley has several proprietary technologies and a growing intellectual property portfolio. Its main scientific programs include ICVT (Ionic Contra Viral Therapy), the Intracellular Herpes Vaccine, the Preps Vaccine and antiviral drugs.
|
